Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2021-05-18 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Board Recommended to the members a final dividend of Rs 15/- (300%) per equity share of Rs 5 each. The final dividend amount, if declared by the Shareholders, are proposed to be ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) disclosing information pursuant to SEBI Listing Regulations. It mentions the Board meeting approving audited financial results for the quarter and year ended 31st March 2021, along with audit reports. It also discusses dividend recommendations and a proposal for issuance of equity shares through QIP to be approved at the upcoming AGM. The document is relatively short (3175 characters) and primarily serves as an announcement of the approval and recommendation of financial results and other corporate actions, rather than containing the full financial statements or detailed analysis. It also references that the full audited financial results and audit reports are enclosed or will be published on the company website. This fits the pattern of a Regulatory Filing (RNS) or possibly a Report Publication Announcement (RPA). However, since it includes the actual approval of audited financial results and dividend recommendations, and is a formal disclosure under SEBI regulations, it is best classified as a Regulatory Filing (RNS).
2021-05-18 English
Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Friday, 18th June, 2021 as the Record Date for taking record of the Members of the Company entitled for the purpose ....
Notice of Dividend Amount Classification · 95% confidence The document is a short notice (1652 characters) addressed to the stock exchange regarding the fixing of a Record Date for determining shareholders entitled to receive a final dividend for the fiscal year 2020-21. It references Regulation 42 of the SEBI Listing Regulations and specifies the date for the dividend record. There is no financial data, analysis, or detailed report content. The document is an announcement related to dividend payment details, specifically the Record Date, which is a key part of dividend distribution process. According to the filing definitions and rules, such announcements about dividend dates and entitlements fall under 'Notice of Dividend Amount' (DIV). The document is not a full report, nor a report publication announcement, but a formal notice about dividend-related record date.
2021-05-18 English
Record Date
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) disclosing information pursuant to SEBI Listing Regulations. It reports that the Board has approved audited financial results for the quarter and year ended 31st March 2021, and that audit reports with unmodified opinion are enclosed. It also mentions a press release on financial results and dividend recommendations, as well as a proposal for issuance of equity shares through QIP to be approved at the upcoming AGM. The document is relatively short (3320 characters) and primarily serves as an announcement of the approval and disclosure of audited financial results and related matters, rather than containing the full financial statements or detailed analysis itself. Therefore, it is an announcement of financial results and related corporate actions, not the full Annual Report or Audit Report. Given the nature and length, it fits best as a Regulatory Filing (RNS) under SEBI regulations, reporting the board meeting outcomes and financial results approval.
2021-05-18 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) disclosing information pursuant to SEBI Listing Regulations. It announces the approval of audited financial results for the quarter and year ended 31 March 2021, including audit reports with unmodified opinion. It also mentions a press release on financial results and a recommended final dividend. Additionally, it discusses a proposal for issuance of equity shares through Qualified Institutional Placement (QIP) to be approved at the upcoming AGM. The document is relatively short (3491 characters) and primarily serves as an announcement of the financial results and related corporate actions rather than containing the full financial statements or detailed analysis. It also references that the full audited results and press release are enclosed or available on the company website. Therefore, this document is best classified as a Regulatory Filing (RNS) since it is an official announcement of financial results and corporate actions without the full report itself.
2021-05-18 English
The Board Recommended to the members a final dividend of Rs 15/- (300%) per equity share of Rs 5 each. The final dividend amount, if declared by the Shareholders, are proposed to be ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) disclosing information pursuant to SEBI Listing Regulations. It mentions the Board meeting approving audited financial results for the quarter and year ended 31st March 2021, along with audit reports. It also discusses dividend recommendations and a proposal for issuance of equity shares through QIP. The document includes a press release on financial results and states that the audited results will be published on the company's website. The document length is 3175 characters, which is relatively short and primarily serves as an announcement of the approval and disclosure of financial results and other corporate actions. It does not contain the full financial statements or detailed financial analysis itself. Therefore, according to the MENU VS MEAL RULE, this document is an announcement related to financial results and corporate actions rather than the full Annual Report or Interim Report. It is best classified as a Regulatory Filing (RNS) because it is a formal disclosure under SEBI regulations, reporting board decisions and financial results approval without the full report attached.
2021-05-18 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) dated 18th May 2021, enclosing a presentation to analysts on the audited financial results for the quarter and year ended 31st March 2021. The content includes summary revenue data for Q4 FY21 and FY21 compared to prior periods. The document is relatively short (1906 characters) and explicitly states it is a presentation to analysts on audited financial results. This matches the definition of an Investor Presentation (IP), which is a detailed presentation for investors focusing on financials, strategy, and market position. It is not the full annual report or earnings release but a presentation accompanying the results. Therefore, the correct classification is Investor Presentation (IP).
2021-05-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.